Why Candel Therapeutics (CADL) Stock Fell 5.09% in 10 Minutes After Q3 Earnings on Nov 12, 2026
EPS of -0.28 came in above the -0.35 estimate.
- CADL fell 5.09% in the 10 minutes after the 16:32:30 ET headline, from $5.30 to $5.03.
- 139,067 shares changed hands in those 10 minutes.
- The headline crossed in after-hours trading, 32 minutes after the 4:00 ET close.
16:32:30 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| CADL | 5.30 | 5.30 | 5.19 | 5.03 | -2.08% | -5.09% |
Candel Therapeutics (CADL) shares fell 5.09% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 16:32:30 ET on Thursday, November 12, 2026. EPS of -0.28 came in above the -0.35 estimate.
CADL in the first 10 minutes
The line that crossed at 16:32:30 ET: “CADL Q3: EPS -0.28 vs -0.35 est”
From a reference price of $5.30 just before the headline, the stock was down 2.08% after one minute and down 5.09%, at $5.03, after 10 minutes. The move kept building after the first minute. 139,067 shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 32 minutes after the 4:00 ET close.
Candel Therapeutics Q3 results against estimates
| Measure | Reported | Estimate | Result |
|---|---|---|---|
| EPS | -0.28 | -0.35 | Beat |
How CADL traded after earlier earnings releases
| Report | EPS vs estimate | Revenue vs estimate | First move |
|---|---|---|---|
| Aug 13, 2026 | -0.52 vs -0.23 | — | not measured |
Other CADL headlines on November 12, 2026
- 16:24 ET: “Candel Therapeutics signs agreement allowing it to offer up to $50 million in common stock through Jefferies, SEC filing shows” (-8.04% in 10 minutes)
Candel Therapeutics at a glance
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Market value | $715 million (as of Nov 12, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
How did Candel Therapeutics stock react to its Q3 earnings on November 12, 2026?
The stock fell 5.09% in the 10 minutes after its Q3 results crossed at 16:32:30 ET. EPS of -0.28 came in above the -0.35 estimate.
How far did CADL move after the headline?
From $5.30 just before the headline to $5.03 10 minutes later, a -5.09% move.
Sources
-
CADL headline and measured reaction, Nov 12, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free